Neviral logo

Neviral – Alembic Pharmaceuticals

Registered App ID 1015281 Class 5 Device

Trademark information

IP India · live record
Application ID
1015281
Status
Registered
Sub status
—
Date of application
07 June 2001
Classes
5
Type
Device
Proprietor
Alembic Pharmaceuticals Public Alembic Road, Vadodara 390 003
Attorney
Nanavati & Nanavati Advocates[2789]7th Floor, Corporate House, Sarkhej Gandhinagar Highway, Judges Bunglows Cross Road, Bodakdev, Ahmedabad 380054, Gujarat
State
Gujarat
Filing mode
Branch Office
IP office
Ahmedabad
Used since
—
Valid / upto
07 June 2031

Goods & services

Class 5

Class 5medicinal and pharmaceutical and veterinary preparations, substances and products (including but no limited to) medicinal and pharmaceutical perorations, substances and products for treatment of hiv, and anti hiv drugs, medicinal and pharmaceutical preparation, substances and products.

PR details

REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 07/06/2011 ADVERTISED IN JOURNAL NO. 1504

PURSUANT TO A REQUEST ON FORM TM-24 DATED 09/09/2011 AND ORDER THEREON DATED 08/02/2013 ALEMBIC PHARMACEUTICALS LIMITED HAS BEEN BROUGHT ON RECORD AS SUBSEQUENT PROPRIETOR IN RESPECT OF THE SAID REGISTERED TRADE MARK BY VIRTUE OF ORDER OF GUJARAT HIGH COURT DATED 24/01/2011 W.E.F. 01/04/2011, CERTIFICATE OF INCORPORATION DATED 31/05/199, 16/06/2010, 12/03/2011

PURSUANT TO A REQUEST ON FORM TM-50 DATED 02/02/2016 AND ORDER THEREON DATED 28/03/2016 THE ADDRESS FOR SERVICE IS ALTERED TO NANAVATI & NANAVATI ADVOCATES , 7TH FLOOR, CORPORATE HOUSE, SARKHEJ - GANDHINAGAR HIGHWAY, JUDGES BUNGLOWS CROSS ROAD, BODAKDEV, AHMEDABAD - 380054, GUJARAT

REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 07/06/2021 ADVERTISED IN JOURNAL NO. 2044

Mark image

Device

Frequently asked questions

Neviral was applied for on 07 June 2001.

The application was filed by Alembic Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Neviral is 1015281.

Trademark attorney Nanavati & Nanavati Advocates.